126 related articles for article (PubMed ID: 15905193)
1. AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping.
Hoffmann C; Tiemann M; Schrader C; Janssen D; Wolf E; Vierbuchen M; Parwaresch R; Ernestus K; Plettenberg A; Stoehr A; Fatkenheuer G; Wyen C; Oette M; Horst HA
Blood; 2005 Sep; 106(5):1762-9. PubMed ID: 15905193
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.
Colomo L; López-Guillermo A; Perales M; Rives S; Martínez A; Bosch F; Colomer D; Falini B; Montserrat E; Campo E
Blood; 2003 Jan; 101(1):78-84. PubMed ID: 12393466
[TBL] [Abstract][Full Text] [Related]
3. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics.
Anderson JJ; Fordham S; Overman L; Dignum H; Wood K; Proctor SJ; Crosier S; Angus B; Culpin RE; Mainou-Fowler T
Int J Oncol; 2009 Nov; 35(5):961-71. PubMed ID: 19787248
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.
Veelken H; Vik Dannheim S; Schulte Moenting J; Martens UM; Finke J; Schmitt-Graeff A
Ann Oncol; 2007 May; 18(5):931-9. PubMed ID: 17395602
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.
van Imhoff GW; Boerma EJ; van der Holt B; Schuuring E; Verdonck LF; Kluin-Nelemans HC; Kluin PM
J Clin Oncol; 2006 Sep; 24(25):4135-42. PubMed ID: 16943530
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas.
Carbone A; Gloghini A; Larocca LM; Capello D; Pierconti F; Canzonieri V; Tirelli U; Dalla-Favera R; Gaidano G
Blood; 2001 Feb; 97(3):744-51. PubMed ID: 11157493
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
[TBL] [Abstract][Full Text] [Related]
10. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
[TBL] [Abstract][Full Text] [Related]
11. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
Zinzani PL; Dirnhofer S; Sabattini E; Alinari L; Piccaluga PP; Stefoni V; Tani M; Musuraca G; Marchi E; Falini B; Baccarani M; Pileri SA
Haematologica; 2005 Mar; 90(3):341-7. PubMed ID: 15749666
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.
Chang CC; McClintock S; Cleveland RP; Trzpuc T; Vesole DH; Logan B; Kajdacsy-Balla A; Perkins SL
Am J Surg Pathol; 2004 Apr; 28(4):464-70. PubMed ID: 15087665
[TBL] [Abstract][Full Text] [Related]
13. Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
Wyen C; Jensen B; Hentrich M; Siehl J; Sabranski M; Esser S; Gillor D; Müller M; Van Lunzen J; Wolf T; Bogner JR; Wasmuth JC; Christ H; Fätkenheuer G; Hoffmann C
AIDS; 2012 Feb; 26(4):457-64. PubMed ID: 22112600
[TBL] [Abstract][Full Text] [Related]
14. Expression of immunohistochemical markers in patients with AIDS-related lymphoma.
Barreto L; Azambuja D; Morais JC
Braz J Infect Dis; 2012; 16(1):74-7. PubMed ID: 22358360
[TBL] [Abstract][Full Text] [Related]
15. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.
Petit B; Chaury MP; Le Clorennec C; Jaccard A; Gachard N; Moalic-Judge S; Labrousse F; Cogné M; Bordessoule D; Feuillard J
Haematologica; 2005 Feb; 90(2):200-6. PubMed ID: 15710572
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Carbone A; Gaidano G; Gloghini A; Larocca LM; Capello D; Canzonieri V; Antinori A; Tirelli U; Falini B; Dalla-Favera R
Blood; 1998 Feb; 91(3):747-55. PubMed ID: 9446632
[TBL] [Abstract][Full Text] [Related]
17. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
18. [Significance of CD138 in immunohistochemical profiles and its correlation with prognosis in diffuse large B-cell lymphoma].
Zhang HW; Chen ZW; Wang JF; Cheng NL
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):115-20. PubMed ID: 21575479
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor.
Oh YH; Park CK
J Korean Med Sci; 2006 Jun; 21(3):397-405. PubMed ID: 16778379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
